Canonical ID: NK-QfFkwcpTeaFHBpwC4e2GeA
· Entity type: Company
(reference)
Property | Value | Lang | Source dataset | Source ID | First seen | ||
---|---|---|---|---|---|---|---|
LegalEntity:address | AHMED KHAIR STREET, 11111 KHARTOUM, SDN | eng | us_sam_exclusions | usgsa-s4mrvqqh0 | |||
LegalEntity:address | AHMED KHAIR STREET, 11111 KHARTOUM, SDN | eng | us_sam_exclusions | usgsa-s4mrvqhwx | |||
LegalEntity:address | AHMED KHAIR STREET, 11111 KHARTOUM, SDN | eng | us_sam_exclusions | usgsa-s4mrvqp60 | |||
Organization:address | Ahmed Khair Street, Khartoum 11111 | fra | fr_tresor_gels_avoir | fr-ga-7112 | |||
Organization:address | Ahmed Khair Street, 11111 Khartoum, SUDAN | be_fod_sanctions | eu-fsf-eu-11097-27 | ||||
Organization:address | Ahmed Khair Street, 11111 Khartoum, Sudan | eng | gb_fcdo_sanctions | gb-fcdo-sud0010 | |||
Organization:address | Ahmed Khair Street, Khartoum, Sudan, 11111 | eng | gb_coh_disqualified | gb-coh-swwsm-n6bfso9gnhc1ioyxrenbq | |||
Organization:address | Ahmed Khair Street, 11111 Khartoum, SUDAN | eu_fsf | eu-fsf-eu-11097-27 | ||||
Organization:address | Ahmed Khair Street, 11111 Khartoum | eng | us_ofac_sdn | ofac-45288 | |||
LegalEntity:address | Ahmed Khair Street, 11111 Khartoum, Sudan | ch_seco_sanctions | ch-seco-73715 | ||||
Organization:address | Ahmed Khair Street, Khartoum 11111, Soudan | fra | mc_fund_freezes | mc-freezes-fce8cd441c161d7708ba9c08a326ae53f8e2358e | |||
Company:address | Sudan (North) | permid | permid-5086676964 | ||||
LegalEntity:address | AHMED KHAIR STREET, 11111 KHARTOUM, SDN | eng | us_sam_exclusions | usgsa-s4mrvqghp | |||
LegalEntity:address | Ahmed Khair Street, Khartoum, 11111 | eng | gb_hmt_sanctions | gb-hmt-16008 | |||
Organization:addressEntity | addr-33dab5b8a1c5cff5a7ecd89584bdfb0537789bf4 | eng | us_ofac_sdn | ofac-45288 | |||
LegalEntity:addressEntity | addr-f50fc4c4b7795ef4bb918bb67a8a6b4e74e46178 | ch_seco_sanctions | ch-seco-73715 | ||||
LegalEntity:addressEntity | addr-795c2bc9d14fa8d3ca63bacf49c05486ab0eb661 | eng | gb_hmt_sanctions | gb-hmt-16008 | |||
Organization:addressEntity | addr-f50fc4c4b7795ef4bb918bb67a8a6b4e74e46178 | be_fod_sanctions | eu-fsf-eu-11097-27 | ||||
Organization:addressEntity | addr-f50fc4c4b7795ef4bb918bb67a8a6b4e74e46178 | eu_fsf | eu-fsf-eu-11097-27 | ||||
LegalEntity:alias | GSK Advance | ca_dfatd_sema_sanctions | ca-sema-5e673fd66cb1125630cca1bd07abd7d4d227338f | ||||
LegalEntity:alias | GSK Advance Co. Ltd | eng | gb_hmt_sanctions | gb-hmt-16008 | |||
LegalEntity:alias | GSK Advance | eng | gb_hmt_sanctions | gb-hmt-16008 | |||
LegalEntity:alias | GSK Advance Co. Ltd. and GSK for Advanced Business Co. Ltd. | ca_dfatd_sema_sanctions | ca-sema-5e673fd66cb1125630cca1bd07abd7d4d227338f | ||||
LegalEntity:alias | شركة جي أس كيه أدفانس كومباني لميتد | ca_dfatd_sema_sanctions | ca-sema-5e673fd66cb1125630cca1bd07abd7d4d227338f | ||||
Organization:alias | GSK for Advanced Business Co. Ltd | eng | us_ofac_sdn | ofac-45288 | |||
LegalEntity:country | sd | eng | gb_hmt_sanctions | gb-hmt-16008 | |||
LegalEntity:country | sd | eng | us_sam_exclusions | usgsa-s4mrvqghp | |||
LegalEntity:country | sd | eng | us_sam_exclusions | usgsa-s4mrvqp60 | |||
Organization:country | sd | eng | us_ofac_sdn | ofac-45288 | |||
Organization:country | sd | eu_fsf | eu-fsf-eu-11097-27 | ||||
Organization:country | sd | fra | fr_tresor_gels_avoir | fr-ga-7112 | |||
LegalEntity:country | sd | ca_dfatd_sema_sanctions | ca-sema-5e673fd66cb1125630cca1bd07abd7d4d227338f | ||||
LegalEntity:country | sd | eng | us_sam_exclusions | usgsa-s4mrvqhwx | |||
Company:country | sd | permid | permid-5086676964 | ||||
LegalEntity:country | sd | eng | us_sam_exclusions | usgsa-s4mrvqqh0 | |||
LegalEntity:country | sd | ch_seco_sanctions | ch-seco-73715 | ||||
Organization:country | sd | be_fod_sanctions | eu-fsf-eu-11097-27 | ||||
Organization:country | sd | eng | gb_fcdo_sanctions | gb-fcdo-sud0010 | |||
LegalEntity:createdAt | 2025-02-13 | eng | us_sam_exclusions | usgsa-s4mrvqghp | |||
LegalEntity:createdAt | 2023-07-12 | eng | gb_hmt_sanctions | gb-hmt-16008 | |||
LegalEntity:createdAt | 2024-04-10 | ch_seco_sanctions | ch-seco-73715 | ||||
LegalEntity:createdAt | 2025-02-14 | eng | us_sam_exclusions | usgsa-s4mrvqp60 | |||
LegalEntity:createdAt | 2025-02-13 | eng | us_sam_exclusions | usgsa-s4mrvqhwx | |||
LegalEntity:createdAt | 2025-02-14 | eng | us_sam_exclusions | usgsa-s4mrvqqh0 | |||
LegalEntity:id | cf431519c1ce66d7313b16e317d415a71b8befcf | eng | us_sam_exclusions | usgsa-s4mrvqqh0 | |||
LegalEntity:id | b06cd4661a2871ea87eef636c3c1296703074f60 | ch_seco_sanctions | ch-seco-73715 | ||||
LegalEntity:id | b4319c4fa2484cd767956d51ea9bd32b9480b586 | eng | gb_hmt_sanctions | gb-hmt-16008 | |||
LegalEntity:id | 6dce1fab483a864d6ca5e741cbfb22b8800b88fe | eng | gb_hmt_sanctions | gb-hmt-16008 | |||
LegalEntity:id | d052a7ed8c01f0cfddadd730403fc3a06542ee5a | eng | gb_hmt_sanctions | gb-hmt-16008 | |||
Organization:id | ffeab28a2b6afb999be4c9d33210b0d52656b022 | be_fod_sanctions | eu-fsf-eu-11097-27 | ||||
Organization:id | 69be1749378f07e84da8204cf719652ee53c72c4 | eng | us_ofac_sdn | ofac-45288 | |||
Organization:id | e9343fc199762a32a9069e8aa61b2e1619813d33 | eng | gb_coh_disqualified | gb-coh-swwsm-n6bfso9gnhc1ioyxrenbq | |||
Organization:id | 94a357858224290b67a86ed8f0d153eb3c83fbb5 | eng | gb_fcdo_sanctions | gb-fcdo-sud0010 | |||
LegalEntity:id | e10d184d72ac8f85f9f31011542239b3f5b431ac | ca_dfatd_sema_sanctions | ca-sema-5e673fd66cb1125630cca1bd07abd7d4d227338f | ||||
Organization:id | d3e12e942d40ccdcf5500199d3af7a90cc44dd2e | us_trade_csl | ofac-45288 | ||||
Organization:id | 67557f2fc52649fe04429e8d1eb625afd352f493 | fra | fr_tresor_gels_avoir | fr-ga-7112 | |||
Organization:id | 5ae5a4fc57b9d91955a8a7396c5a838807ca3ffc | eu_fsf | eu-fsf-eu-11097-27 | ||||
Organization:id | 2c2c42b4238ac5d9141d33934c648ced68d6b22c | fra | mc_fund_freezes | mc-freezes-fce8cd441c161d7708ba9c08a326ae53f8e2358e | |||
Company:id | 6748437721ea5ff49517461a1e585efe7f036d8f | permid | permid-5086676964 | ||||
LegalEntity:id | f4daa6aac0861970703bbdb25a2a7a11d7a62371 | eng | us_sam_exclusions | usgsa-s4mrvqghp | |||
LegalEntity:id | 40be8bfdb51199a1dc672c07b6f32c54306ee96c | eng | us_sam_exclusions | usgsa-s4mrvqhwx | |||
LegalEntity:id | e1a0390be4a827ddbd0da935ee64a98168d73b4c | eng | us_sam_exclusions | usgsa-s4mrvqp60 | |||
Company:jurisdiction | sd | permid | permid-5086676964 | ||||
Organization:legalForm | Limited Company | fra | fr_tresor_gels_avoir | fr-ga-7112 | |||
LegalEntity:legalForm | Limited Company | ch_seco_sanctions | ch-seco-73715 | ||||
Organization:modifiedAt | 2024-01-22 | be_fod_sanctions | eu-fsf-eu-11097-27 | ||||
LegalEntity:modifiedAt | 2023-07-12 | eng | gb_hmt_sanctions | gb-hmt-16008 | |||
Organization:modifiedAt | 2024-01-22 | eu_fsf | eu-fsf-eu-11097-27 | ||||
LegalEntity:modifiedAt | 2024-04-10 | ch_seco_sanctions | ch-seco-73715 | ||||
LegalEntity:name | GSK ADVANCE COMPANY LTD | ch_seco_sanctions | ch-seco-73715 | ||||
LegalEntity:name | GSK Advance Company Ltd. | ca_dfatd_sema_sanctions | ca-sema-5e673fd66cb1125630cca1bd07abd7d4d227338f | ||||
Organization:name | GSK Advance Company Ltd | eng | gb_coh_disqualified | gb-coh-swwsm-n6bfso9gnhc1ioyxrenbq | |||
Organization:name | GSK ADVANCE COMPANY LTD | us_trade_csl | ofac-45288 | ||||
Organization:name | GSK ADVANCE COMPANY LTD | fra | fr_tresor_gels_avoir | fr-ga-7112 | |||
Organization:name | GSK ADVANCE COMPANY LTD | eng | eu_fsf | eu-fsf-eu-11097-27 | |||
Organization:name | GSK Advance Company LTD | eng | us_ofac_sdn | ofac-45288 | |||
Organization:name | GSK ADVANCE COMPANY LTD | eng | be_fod_sanctions | eu-fsf-eu-11097-27 | |||
Organization:name | GSK ADVANCE COMPANY LTD | fra | mc_fund_freezes | mc-freezes-fce8cd441c161d7708ba9c08a326ae53f8e2358e | |||
Company:name | Gsk Advance Co Ltd | permid | permid-5086676964 | ||||
LegalEntity:name | GSK FOR ADVANCED BUSINESS CO. LTD | eng | us_sam_exclusions | usgsa-s4mrvqqh0 | |||
LegalEntity:name | GSK ADVANCE COMPANY LTD | eng | us_sam_exclusions | usgsa-s4mrvqghp | |||
LegalEntity:name | GSK ADVANCE COMPANY LTD | eng | us_sam_exclusions | usgsa-s4mrvqhwx | |||
LegalEntity:name | GSK Advance Company Ltd | eng | gb_hmt_sanctions | gb-hmt-16008 | |||
LegalEntity:name | GSK FOR ADVANCED BUSINESS CO. LTD | eng | us_sam_exclusions | usgsa-s4mrvqp60 | |||
Organization:name | GSK Advance Company Ltd | eng | gb_fcdo_sanctions | gb-fcdo-sud0010 | |||
Organization:name | GSK Advance Co. Ltd | eng | gb_fcdo_sanctions | gb-fcdo-sud0010 | |||
Organization:name | GSK Advance | eng | gb_fcdo_sanctions | gb-fcdo-sud0010 | |||
Organization:notes | The Director Disqualification Sanction was imposed on 09/04/2025. | eng | gb_fcdo_sanctions | gb-fcdo-sud0010 | |||
Organization:notes | Disqualified | eng | gb_coh_disqualified | gb-coh-swwsm-n6bfso9gnhc1ioyxrenbq | |||
Organization:notes | Type of entity: Limited Company. 60 % owned by Major Algoney Hamdan Dagalo | eu_fsf | eu-fsf-eu-11097-27 | ||||
LegalEntity:notes | (also GSK ADVANCE COMPANY LTD) | eng | us_sam_exclusions | usgsa-s4mrvqp60 | |||
LegalEntity:notes | (also GSK ADVANCE COMPANY LTD) | eng | us_sam_exclusions | usgsa-s4mrvqqh0 | |||
Organization:notes | GSK est une société soudanaise dans le domaine des technologies de l'information et de la sécurité, qui est détenue, à 60 % de l'actionnariat, par Algoney Hamdan Dagalo, commandant au sein des FSR et le plus jeune frère de Mohamed Hamdan Dagalo (Hemedti). GSK fait du réseau commercial des FSR qui génère un revenu stable pour les FSR leur permettant de financer et de poursuivre le conflit au Soudan. Elle est utilisée par les FSR comme société écran, facilitant les flux de liquidités vers les FSR et impliquée dans les procédures de passation de marchés des FSR. En outre, depuis au moins 2019, GSK travaille avec Aviatrade LLC, une entreprise d'approvisionnement militaire établie en Russie, pour l'achat et la fourniture de matériel et d’équipements au profit des FSR, y compris la formation correspondante, et pour l’achat et la fourniture de véhicules aériens sans pilote, d’équipements de surveillance et de pièces détachées. Des drones de reconnaissance et piégés sont utilisés par les FSR dans le conflit au Soudan. Par conséquent, GSK Advance Company LTD apporte un soutien aux actions des FSR qui menacent la paix, la stabilité et la sécurité du Soudan. | fra | fr_tresor_gels_avoir | fr-ga-7112 | |||
Organization:notes | Type of entity: Limited Company. 60 % owned by Major Algoney Hamdan Dagalo | be_fod_sanctions | eu-fsf-eu-11097-27 | ||||
Organization:notes | Type d'entité: société à responsabilité limitée (Limited Company). | fra | mc_fund_freezes | mc-freezes-fce8cd441c161d7708ba9c08a326ae53f8e2358e | |||
LegalEntity:notes | GSK is a Sudan-based information technology and security company, which is 60 % owned by RSF Major Algoney Hamdan Dagalo, the youngest brother of Mohamed Hamdan Dagalo (Hemedti). GSK is part of the RSF’s commercial network which generates stable revenue for the RSF enabling them to finance and continue the conflict in Sudan. It is used by the RSF as a front company, facilitating cash flows into the RSF and being involved in the RSF’s procurement processes. In addition, since at least 2019, GSK has been working with Aviatrade LLC, a Russia-based military supply company, on the purchase and supply of material and equipment for the benefit of the RSF, including the corresponding training, and on the purchase and supply of unmanned aerial vehicles, monitoring equipment and spare parts. Reconnaissance and weaponised drones are used by the RSF in the conflict in Sudan. Therefore, GSK Advance Company LTD provides support for RSF actions that threaten the peace, stability and security of Sudan. | ch_seco_sanctions | ch-seco-73715 | ||||
LegalEntity:notes | (also GSK FOR ADVANCED BUSINESS CO. LTD, GSK FOR ADVANCED BUSINESS CO. LTD) | eng | us_sam_exclusions | usgsa-s4mrvqhwx | |||
Company:permId | 5086676964 | permid | permid-5086676964 | ||||
LegalEntity:phone | +249930020401 | eng | gb_hmt_sanctions | gb-hmt-16008 | |||
Organization:phone | +249930020401 | eng | gb_fcdo_sanctions | gb-fcdo-sud0010 |